GEMINI-NSCLC is a study for people with Non-Small Cell Lung Cancer (NSCLC). It's non-interventional, meaning no new treatment is given. Instead, it collects health and blood data during regular cancer care. The aim is to learn how lung cancer changes over time and see if blood tests can predict cancer's return or treatment success.
To join, you need to be 18 or older with NSCLC, and must give consent for blood samples. Participants are divided into two groups: Cohort 1 (early-stage cancer) and Cohort 2 (advanced cancer). Cohort 1 includes those who had or plan surgery, while Cohort 2 is for patients needing immunotherapy. Some health conditions may prevent joining.
- The study requires regular blood samples during your usual doctor visits.
- No new treatments are provided; it works alongside your regular cancer care.
- Participation includes sharing your medical records and tumor samples.